LU81726A1 - Furannes substitues - Google Patents

Furannes substitues Download PDF

Info

Publication number
LU81726A1
LU81726A1 LU81726A LU81726A LU81726A1 LU 81726 A1 LU81726 A1 LU 81726A1 LU 81726 A LU81726 A LU 81726A LU 81726 A LU81726 A LU 81726A LU 81726 A1 LU81726 A1 LU 81726A1
Authority
LU
Luxembourg
Prior art keywords
radical
compound
formula
methylthio
furyl
Prior art date
Application number
LU81726A
Other languages
English (en)
French (fr)
Inventor
R Crenshaw
A Algieri
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of LU81726A1 publication Critical patent/LU81726A1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
LU81726A 1978-09-26 1979-09-26 Furannes substitues LU81726A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/945,968 US4203909A (en) 1978-09-26 1978-09-26 Furan compounds
US94596878 1978-09-26

Publications (1)

Publication Number Publication Date
LU81726A1 true LU81726A1 (fr) 1980-05-07

Family

ID=25483767

Family Applications (1)

Application Number Title Priority Date Filing Date
LU81726A LU81726A1 (fr) 1978-09-26 1979-09-26 Furannes substitues

Country Status (29)

Country Link
US (1) US4203909A (fi)
JP (1) JPS5547670A (fi)
KR (1) KR840001019B1 (fi)
AT (1) AT376967B (fi)
AU (1) AU525020B2 (fi)
BE (1) BE879024A (fi)
CA (1) CA1148556A (fi)
CH (1) CH641794A5 (fi)
CY (1) CY1275A (fi)
DE (1) DE2938990A1 (fi)
DK (1) DK151255C (fi)
ES (1) ES8100284A1 (fi)
FI (1) FI74959C (fi)
FR (1) FR2437409A1 (fi)
GB (1) GB2030985B (fi)
GR (1) GR74126B (fi)
HK (1) HK1485A (fi)
HU (1) HU181408B (fi)
IE (1) IE48946B1 (fi)
IL (1) IL58300A (fi)
IT (1) IT1164705B (fi)
KE (1) KE3486A (fi)
LU (1) LU81726A1 (fi)
MY (1) MY8500948A (fi)
NL (1) NL7907066A (fi)
PH (1) PH16952A (fi)
SE (1) SE446095B (fi)
YU (1) YU41442B (fi)
ZA (1) ZA794996B (fi)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5444660A (en) * 1977-08-29 1979-04-09 Yamanouchi Pharmaceut Co Ltd Heterocyclic compound and its preparation
US4233302A (en) * 1977-12-23 1980-11-11 Glaxo Group Limited Amine derivatives and pharmaceutical compositions containing them
US4282363A (en) * 1978-11-24 1981-08-04 Bristol-Myers Company 1-Nitro-2-(2-alkynylamino)-2-[(2-pyridylmethylthio)-ethylamino]ethylene derivatives
EP0057981A3 (en) 1981-02-09 1982-08-25 Beecham Group Plc Aromatic compounds, processes for their preparation and their use
WO1983002113A1 (en) * 1981-12-17 1983-06-23 Yuki, Hiroshi Propenylamine derivatives and drug containing same
PT76557B (en) * 1982-04-16 1986-01-21 Inke Sa Process for preparing furan derivatives and addition salts thereof and of pharmaceutical compositions containing the same
DE3343884A1 (de) * 1982-12-08 1984-06-14 Degussa Ag, 6000 Frankfurt Neue ethendiamin- und guanidin-derivate
NL8303965A (nl) * 1982-12-08 1984-07-02 Degussa Nieuwe etheendiamine- en guanidine-derivaten; werkwijze voor het bereiden daarvan; geneesmiddelen die ze bevatten; werkwijze voor het bereiden van dergelijke geneesmiddelen; toepassing van de verbindingen voor het bereiden van geneesmiddelen en in de geneeskunde.
GB8313217D0 (en) * 1983-05-13 1983-06-22 Glaxo Group Ltd Pharmaceutical compositions
HU196979B (en) * 1985-01-11 1989-02-28 Gyogyszerkutato Intezet Process for producing basic thioether and salt
EP4196793A1 (en) 2020-08-11 2023-06-21 Université de Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1553070A (en) 1975-05-21 1979-09-19 Smith Kline French Lab Thiourea guanidine and 1-nitro-2,2-diaminoethylene derivatives
GB1565966A (en) * 1976-08-04 1980-04-23 Allen & Hanburys Ltd Aminoalkyl furan derivatives
CY1077A (en) * 1976-08-04 1980-12-27 Allen & Hanburys Ltd Aminoalkyl furan derivatives
DE2724070A1 (de) * 1977-05-27 1978-12-07 Bayerische Motoren Werke Ag Schaltvorrichtung fuer ausruestungsbauteilen von kraftfahrzeugen zugeordnete stromverbraucher
US4112234A (en) * 1977-08-22 1978-09-05 Bristol-Myers Company Imidazolylmethylthioethyl alkynyl guanidines

Also Published As

Publication number Publication date
JPS5547670A (en) 1980-04-04
HU181408B (en) 1983-07-28
MY8500948A (en) 1985-12-31
GB2030985A (en) 1980-04-16
AU525020B2 (en) 1982-10-14
CA1148556A (en) 1983-06-21
ES484446A0 (es) 1980-11-01
DE2938990C2 (fi) 1987-09-03
JPS618835B2 (fi) 1986-03-18
FI74959B (fi) 1987-12-31
YU41442B (en) 1987-06-30
HK1485A (en) 1985-01-11
BE879024A (fr) 1980-03-26
NL7907066A (nl) 1980-03-28
FI792974A (fi) 1980-03-27
DK151255C (da) 1988-05-24
YU228479A (en) 1983-02-28
IL58300A (en) 1984-01-31
IT1164705B (it) 1987-04-15
DK151255B (da) 1987-11-16
IE48946B1 (en) 1985-06-26
ATA630179A (de) 1984-06-15
FR2437409A1 (fr) 1980-04-25
KR840001019B1 (ko) 1984-07-20
CH641794A5 (de) 1984-03-15
DK401679A (da) 1980-03-27
CY1275A (en) 1985-03-08
GB2030985B (en) 1982-11-17
GR74126B (fi) 1984-06-06
FR2437409B1 (fi) 1983-09-16
ZA794996B (en) 1980-10-29
AT376967B (de) 1985-01-25
SE7907953L (sv) 1980-03-27
ES8100284A1 (es) 1980-11-01
SE446095B (sv) 1986-08-11
US4203909A (en) 1980-05-20
IL58300A0 (en) 1979-12-30
DE2938990A1 (de) 1980-06-04
KE3486A (en) 1985-01-25
AU5086479A (en) 1980-04-03
IE791817L (en) 1980-03-26
IT7950309A0 (it) 1979-09-20
PH16952A (en) 1984-04-24
FI74959C (fi) 1988-04-11

Similar Documents

Publication Publication Date Title
US7754768B2 (en) Methods and compositions for modulating alpha adrenergic receptor activity
KR850000869B1 (ko) 3-페녹시-1-알킬아미노-프로판올-2 유도체의 제조방법
CH634318A5 (fr) Quinazolines.
KR840001075B1 (ko) 티아졸 유도체의 제조방법
EP0087192A1 (fr) Compositions pharmaceutiques contenant de l'acide 3-hydroxybutanoique ou un sel dérivé de cet acide et composés dérivés de l'acide 3-hydroxybutanoique utilisables comme médicament
RU2008119465A (ru) Производные циклопропилуксусной кислоты и их применение
CA1213280A (fr) PROCEDE DE PREPARATION DE NOUVEAUX DERIVES DE 4-(1H- INDOL-3-YL) .alpha.-METHYL PIPERIDINE-1-ETHANOL ET DE LEURS SELS
EP0110781B1 (fr) (Amino-2 éthyl)-6 benzoxazolinones substituées, leur préparation et une composition pharmaceutique les contenant
LU81726A1 (fr) Furannes substitues
KR850000872B1 (ko) 3-페녹시-1-알콕시카르보닐알킬아미노-프로판올-2 유도체의 제조 방법
US20040235912A1 (en) Peroxisome proliferator activated receptor alpha agonists
FR2893616A1 (fr) Nouveaux derives d'indolizine, leur procede de preparation et les compositions therapeutiques les comprenant
LU81554A1 (de) Alkylthiophenoxyalkylamines
US4200760A (en) Imidazolylalkylthioalkylamino-ethylene derivatives
NO151824B (no) Mellomprodukter for fremstilling av guanidinderivater
FR2542741A1 (fr) 3,4-diamino-1,2,5-thiadiazoles substitues possedant une activite antagoniste du recepteur-h2 de l'histamine
EP0180500A1 (fr) Dérivés de thiéno et furo - [2,3-c]pyrroles, procédés de préparation et médicaments les contenant
US4221737A (en) 1-(Alkynyl)amino-1-(mercaptoalkyl)amino ethylenes
EP0430800B1 (fr) Nouvelles benzothiazolinones substituées, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
KR810000632B1 (ko) 히스타민 h₂수용기 길항제 또는 비독성인 그의 약조제 가능한 산 첨가염의 제조방법
FR2658514A1 (fr) Nouveaux derives du methyl-4 thiazole, leurs procedes de preparation et les compositions pharmaceutiques en contenant.
FI76319B (fi) Foerfarande foer framstaellning av nya substituerade 3-fenoxi-1-alkoxikarbonyl-alkylamino-propanol-2 -foereningar med -receptor haemmande verkan.
KR880001429B1 (ko) 치환된 3-아미노-시드논-이민의 제조방법
FR2689126A1 (fr) 2-(imino substitué)-thiazolidines, procédé pour les préparer et utilisation pour la préparation des compositions pharmaceutiques.
LU85550A1 (fr) 2,5-disubstituees-4(3h)-pyrimidones ayant une activite antagoniste receptrice histamine h2,et compositions pharmaceutiques contenant de tels composes a titre d'ingredients actifs